A Selective Omega-3 Fatty Acid Agonist

  • Author: Melania Tesio
  • Published: 03 August 2014
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Nature Medicine/Nature Publishing Group
thumbnail image: A Selective Omega-3 Fatty Acid Agonist

Omega–3 fatty acids are healthy dietary elements abundant in fish. These acids exert potent anti-inflammatory effects and increase the sensitivity to insulin, a hormone regulating glucose uptake from the blood circulation. These effects are elicited following binding to Grp120, a lipid sensing protein. Thus, the pharmacological stimulation of this molecule is a promising strategy to control inflammation and metabolic diseases. Nevertheless, this task is challenging because Grp120’s structural homology to Grp40, another member of the same protein family, limits the development of specific agonists.

Jerrold Olefsky, University of California, San Diego, USA, and colleagues report a way around this issue. The researchers demonstrated that compound A (pictured) is a selective, high-affinity, orally available Gpr120 agonist. When testeted in vitro, this compound exerted potent anti-inflammatory effects. Moreover, when it was administered to obese mice, it increased their sensitivity to the action of insulin.
Compound A could, thus, become a new insulin-sensitizing drug for the treatment of insulin-resistant syndromes such as diabetes.


Article Views: 2325

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH